Anna Mensa-Vilaro
University of Barcelona
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Anna Mensa-Vilaro.
Autoimmunity Reviews | 2016
José Hernández-Rodríguez; Estibaliz Ruiz-Ortiz; Adrià Tomé; Gerard Espinosa; Eva González-Roca; Anna Mensa-Vilaro; Sergio Prieto-González; Georgina Espígol-Frigolé; Josep Mensa; Francesc Cardellach; Josep M. Grau; Maria C. Cid; Jordi Yagüe; Juan I. Aróstegui; Ricard Cervera
INTRODUCTION Autoinflammatory diseases (AID) are usually diagnosed during the pediatric age. However, adult-onset disease or diagnosis during adulthood has been occasionally described. OBJECTIVES To assess the clinical and genetic characteristics of adult patients diagnosed with an AID in an adult referral center for AID. METHODS We retrospectively evaluated clinical and genetic features of adult patients (≥16 years) diagnosed with an AID or referred after AID diagnosis to the Clinical Unit of AID, at the Department of Autoimmune Diseases, Hospital Clínic of Barcelona, from 2008 to 2014. RESULTS During the study period, a genetic study for suspected AID was requested to 90 patients at the Department of Autoimmune Diseases. A final diagnosis of monogenic AID was achieved in 17 patients (19% of patients tested). Five additional cases were diagnosed with periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome and 10 patients with AID were referred from other adult departments. Finally, a total of 32 patients with AID were finally diagnosed or monitored in our Clinical Unit. These included 12 (37.5%) familial Mediterranean fever, 6 (18.8%) tumour necrosis factor-receptor associated periodic syndrome, 8 (25%) cryopirin-associated periodic syndromes (Muckle-Wells syndrome [MWS] or overlap familial cold-associated periodic syndrome/MWS), 1 (3.1%) mevalonate kinase deficiency, and 5 (15.6%) PFAPA. Clinical evidence of disease-onset during childhood and adulthood was observed in 15 (47%) and 17 (53%) patients, respectively. Overall, the final diagnosis was obtained after a delay of a mean of 12 years (range 0-47 years). Compared to children, adult patients with AID in our series presented more frequently with non-severe manifestations and none of them developed amyloidosis during follow-up. Adult patients also carried higher proportion of low-penetrance mutations or polymorphisms and all genetic variants were presented in heterozygosis or as heterozygous compounds. CONCLUSIONS Adult disease-onset or delayed diagnosis of AID during adulthood is associated with milder disease phenotypes, and seem to be driven by mild genotypes, with predominant presence of low-penetrance mutations or polymorphisms.
Arthritis & Rheumatism | 2016
Anna Mensa-Vilaro; Weng Tarng Cham; Swee Ping Tang; Sern Chin Lim; Eva González-Roca; Estibaliz Ruiz-Ortiz; Roziana Ariffin; Jordi Yagüe; Juan I. Aróstegui
Blau syndrome is characterized by noncaseating granulomatous arthritis, dermatitis, and uveitis, and results from gain‐of‐function NOD2 mutations. This study was undertaken to identify the genetic cause of the disease in a family with 3 members with Blau syndrome.
Arthritis & Rheumatism | 2016
Anna Mensa-Vilaro; María Teresa Bosque; Giuliana Magri; Yoshitaka Honda; Helios Martínez-Banaclocha; Marta Casorran‐Berges; Jordi Sintes; Eva González-Roca; Estibaliz Ruiz-Ortiz; Toshio Heike; Juan José Martínez-García; Alberto Baroja-Mazo; Andrea Cerutti; Ryuta Nishikomori; Jordi Yagüe; Pablo Pelegrín; Concha Delgado‐Beltran; Juan I. Aróstegui
Gain‐of‐function NLRP3 mutations cause cryopyrin‐associated periodic syndrome (CAPS), with gene mosaicism playing a relevant role in the pathogenesis. This study was undertaken to characterize the genetic cause underlying late‐onset but otherwise typical CAPS.
Arthritis & Rheumatism | 2015
Anna Mensa-Vilaro; Weng Tarng Cham; Swee Ping Tang; Sern Chin Lim; Eva González-Roca; Estibaliz Ruiz-Ortiz; Roziana Ariffin; Jordi Yagüe; Juan I. Aróstegui
Blau syndrome is characterized by noncaseating granulomatous arthritis, dermatitis, and uveitis, and results from gain‐of‐function NOD2 mutations. This study was undertaken to identify the genetic cause of the disease in a family with 3 members with Blau syndrome.
Arthritis & Rheumatism | 2016
Dorota Rowczenio; Hadija Trojer; Ebun Omoyinmi; Juan I. Aróstegui; Grigor Arakelov; Anna Mensa-Vilaro; Anna Baginska; Caroline Silva Pilorz; Guosu Wang; Thirusha Lane; Paul A. Brogan; Philip N. Hawkins; Helen J. Lachmann
To investigate the molecular cause of persistent fevers in a patient returning from working overseas, in whom investigations for tropical diseases yielded negative results.
Arthritis & Rheumatism | 2016
Anna Mensa-Vilaro; María Teresa Bosque; Giuliana Magri; Yoshitaka Honda; Helios Martínez-Banaclocha; Marta Casorran‐Berges; Jordi Sintes; Eva González-Roca; Estibaliz Ruiz-Ortiz; Toshio Heike; Juan José Martínez-García; Alberto Baroja-Mazo; Andrea Cerutti; Ryuta Nishikomori; Jordi Yagüe; Pablo Pelegrín; Concha Delgado‐Beltran; Juan I. Aróstegui
Gain‐of‐function NLRP3 mutations cause cryopyrin‐associated periodic syndrome (CAPS), with gene mosaicism playing a relevant role in the pathogenesis. This study was undertaken to characterize the genetic cause underlying late‐onset but otherwise typical CAPS.
Annals of the Rheumatic Diseases | 2017
Fiona Moghaddas; Rafael Llamas; Dominic De Nardo; Helios Martínez-Banaclocha; Juan José Martínez-García; Pablo Mesa-del-Castillo; Paul J. Baker; Vanessa Gargallo; Anna Mensa-Vilaro; Scott Canna; Ian P. Wicks; Pablo Pelegrín; Juan I. Aróstegui; Seth L. Masters
Objective Pyrin-Associated Autoinflammation with Neutrophilic Dermatosis (PAAND) is a recently described monogenic autoinflammatory disease. The causal p.S242R MEFV mutation disrupts a binding motif of the regulatory 14-3-3 proteins within pyrin. Here, we investigate a family with clinical features consistent with PAAND in whom the novel p.E244K MEFV mutation, located in the +2 site of the 14-3-3 binding motif in pyrin, has been found. Methods Multiplex cytokine analyses were performed on p.E244K patient and control serum. Peripheral blood mononuclear cells were stimulated ex vivo with lipopolysaccharide (LPS). In vitro, inflammasome complex formation was evaluated by flow cytometry of Apoptosis-associated Speck-like protein containing a Caspase recruitment domain (ASC) specks. Interleukin-1β (IL-1β) and IL-18 production was quantified by ELISA. The ability of the p.E244K pyrin mutation to interact with 14-3-3 was assessed by immunoprecipitation. Results PAAND p.E244K patient serum displayed a different cytokine profile compared with patients with Familial Mediterranean Fever (FMF). In overexpression models, p.E244K pyrin was associated with decreased 14-3-3 binding and increased ASC speck formation. THP-1 monocytes expressing PAAND pyrin mutations demonstrated spontaneous caspase-1-dependent IL-1β and IL-18 secretion, as well as cell death, which were significantly greater than those of wild-type and the FMF-associated mutation p.M694V. Conclusion In PAAND, disruption of the +2 position of a 14-3-3 binding motif in pyrin results in its constitutive activation, with spontaneous production of IL-1β and IL-18, associated with inflammatory cell death. The altered serum cytokine profile may explain the different clinical features exhibited by PAAND patients compared with those with FMF.
Arthritis & Rheumatism | 2016
Dorota Rowczenio; Hadija Trojer; Ebun Omoyinmi; Juan I. Aróstegui; Grigor Arakelov; Anna Mensa-Vilaro; Anna Baginska; Caroline Silva Pilorz; Guosu Wang; Thirusha Lane; Paul A. Brogan; Philip N. Hawkins; Helen J. Lachmann
To investigate the molecular cause of persistent fevers in a patient returning from working overseas, in whom investigations for tropical diseases yielded negative results.
Frontiers in Immunology | 2017
Dorota Rowczenio; Sonia Melo Gomes; Juan I. Aróstegui; Anna Mensa-Vilaro; Ebun Omoyinmi; Hadija Trojer; Anna Baginska; Alberto Baroja-Mazo; Pablo Pelegrín; Sinisa Savic; Thirusha Lane; Rene Williams; Paul A. Brogan; Helen J. Lachmann; Philip N. Hawkins
Cryopyrin-associated periodic syndrome (CAPS) is caused by gain-of-function NLRP3 mutations. Recently, somatic NLRP3 mosaicism has been reported in some CAPS patients who were previously classified as “mutation-negative.” We describe here the clinical and laboratory findings in eight British adult patients who presented with symptoms typical of CAPS other than an onset in mid-late adulthood. All patients underwent comprehensive clinical and laboratory investigations, including analysis of the NLRP3 gene using Sanger and amplicon-based deep sequencing (ADS) along with measurements of extracellular apoptosis-associated speck-like protein with CARD domain (ASC) aggregates. The clinical phenotype in all subjects was consistent with mid-spectrum CAPS, except a median age at disease onset of 50 years. Sanger sequencing of NLRP3 was non-diagnostic but ADS detected a somatic NLRP3 mutation in each case. In one patient, DNA isolated from blood demonstrated an increase in the mutant allele from 5 to 45% over 12 years. ASC aggregates in patients’ serum measured during active disease were significantly higher than healthy controls. This series represents 8% of CAPS patients diagnosed in a single center, suggesting that acquired NLRP3 mutations may not be an uncommon cause of the syndrome and should be sought in all patients with late-onset symptoms otherwise compatible with CAPS. Steadily worsening CAPS symptoms in one patient were associated with clonal expansion of the mutant allele predominantly affecting myeloid cells. Two patients developed AA amyloidosis, which previously has only been reported in CAPS in association with life-long germline NLRP3 mutations.
Pediatric Rheumatology | 2015
Eva González-Roca; Anna Mensa-Vilaro; S Plaza; Mc Anton; J Rius; Estibaliz Ruiz-Ortiz; Josep M. Campistol; Alejandro Souto; Jerónima Cañellas; Kenji Nakagawa; Ryuta Nishikomori; Jordi Yagüe; Juan I. Aróstegui
Familial cold autoinflammatory syndrome, Muckle-Wells syndrome (MWS), and chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome are dominantly inherited autoinflammatory diseases associated to gain-of-function NLRP3 mutations. All these diseases are currently considered as different phenotypes of the cryopyrin-associated periodic syndromes (CAPS). A variable degree of somatic NLRP3 mosaicism has been recently detected in ≈35% of patients with CINCA. However, no data are currently available regarding the relevance of this genetic mechanism in other CAPS phenotypes.